Bruker (BRKRP) Total Debt Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.19% |
| Dec 31, 2025 | 17.22% |
| Sep 30, 2025 | 19.34% |
| Jun 30, 2025 | 18.90% |
| Mar 31, 2025 | 15.90% |
| Dec 31, 2024 | 20.49% |
| Sep 30, 2024 | 34.66% |
| Jun 30, 2024 | 34.29% |
| Mar 31, 2024 | 32.73% |
| Dec 31, 2023 | 30.31% |
| Sep 30, 2023 | 38.35% |
| Jun 30, 2023 | 41.32% |
| Mar 31, 2023 | 40.99% |
| Dec 31, 2022 | 23.42% |
| Sep 30, 2022 | 19.15% |
| Jun 30, 2022 | 22.43% |
| Mar 31, 2022 | 25.88% |
| Dec 31, 2021 | 24.81% |
| Sep 30, 2021 | 17.78% |
| Jun 30, 2021 | 19.31% |
| Mar 31, 2021 | 22.22% |
| Dec 31, 2020 | 25.86% |
| Sep 30, 2020 | 17.45% |
| Jun 30, 2020 | 22.96% |
| Mar 31, 2020 | 23.30% |
| Dec 31, 2019 | 17.73% |
| Sep 30, 2019 | 7.87% |
| Jun 30, 2019 | 6.80% |
| Mar 31, 2019 | -1.17% |
| Dec 31, 2018 | -0.80% |
| Sep 30, 2018 | -7.52% |
| Jun 30, 2018 | -8.10% |
| Mar 31, 2018 | -8.10% |
| Dec 31, 2017 | 4.59% |
| Sep 30, 2017 | 7.36% |
| Jun 30, 2017 | 6.07% |
| Mar 31, 2017 | 3.78% |
| Dec 31, 2016 | 5.97% |
| Sep 30, 2016 | 7.20% |
| Jun 30, 2016 | 6.90% |
| Mar 31, 2016 | 22.42% |
| Dec 31, 2015 | -0.35% |